First-in-human, proof-of-concept clinical trial of MSB-3163
Latest Information Update: 05 Jan 2023
At a glance
- Drugs MSB-3163 (Primary)
- Indications Acne
- Focus Adverse reactions; First in man; Proof of concept
- Sponsors MatriSys Bio
- 04 Jan 2023 According to a MatriSys Bioscience media release, enrolled over 75%, results of this study expected in H1 23.
- 23 Mar 2021 New trial record